See the DrugPatentWatch profile for Mounjaro
Mounjaro's primary patents are set to expire between 2027 and 2037, according to DrugPatentWatch.com [1]. These patent expirations will likely pave the way for generic versions of the drug to enter the market.
When can generic Mounjaro be expected?
The earliest expected patent expiry for Mounjaro is in 2027, with others extending to 2037 [1]. This timeline indicates that generic competition could begin to emerge following these dates, subject to regulatory approvals.
What happens when Mounjaro goes off patent?
Once Mounjaro's patents expire, other pharmaceutical companies will have the opportunity to develop and market generic versions of the drug [1]. This typically leads to increased competition and a reduction in the price of the medication.
How does Mounjaro work?
Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [2]. It is used to improve glycemic control in adults with type 2 diabetes [2].
Who makes Mounjaro?
Mounjaro is manufactured by Eli Lilly and Company [2].
What are the risks associated with Mounjaro?
Common side effects of Mounjaro include nausea, vomiting, diarrhea, decreased appetite, constipation, and abdominal pain [2]. More serious risks can include pancreatitis, gallbladder problems, kidney problems, severe allergic reactions, and a type of thyroid cancer called medullary thyroid carcinoma (MTC) or thyroid C-cell tumors [2].
Are there alternatives to Mounjaro?
For type 2 diabetes management, other medications are available, including GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), as well as other classes of antidiabetic drugs [3]. The choice of treatment depends on individual patient needs and medical advice.
How much does Mounjaro cost?
The retail price of Mounjaro can vary significantly, but it is generally considered an expensive medication. For instance, a 4-week supply can cost over $1,000 [4]. The cost of generic versions after patent expiry is expected to be lower.
What are the key patents for Mounjaro?
DrugPatentWatch.com tracks patents related to Mounjaro, indicating that multiple patents cover the drug's composition of matter, methods of use, and formulations. The expiration dates of these patents determine when generic versions can be produced [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.mounjaro.com/
[3] https://www.niddk.nih.gov/health-information/diabetes/diabetes-medicines
[4] https://www.goodrx.com/mounjaro